Bio Special Special Report
Global Efforts to Stop the Spread of COVID-19 Undermined by Vaccine Side Effect Concerns
As the rate of people receiving COVID-19 vaccinations has slowed, a new survey of physicians has revealed that doctors are working hard to combat vaccine h...
May 20, 2021 | Analysis
Research Spotlight: New Therapeutic Targets Focusing on Aberrant Lipid Metabolism in Alzheimer’s Disease
One of the major challenges we currently face is sparse drug discovery pipelines and low clinical trial success rates due to the variability of dru...
May 12, 2021 | Analysis
The Role of Biomarkers in Drug Discovery for Neurodegenerative Disease
There's a need to propel and reinvigorate the current state of drug discovery pipeline in tackling pressing neurodegenerative disorders such as Alzheimer's...
May 12, 2021 | Opinion
Modernizing the Natural History of Disease Research
The term natural history of disease refers to the progression of a disease process in an individual over time, in the absence of any treatment or...
May 11, 2021 | Analysis
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
